How is Metastatic Breast Cancer Treated? everydayhealth.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from everydayhealth.com Daily Mail and Mail on Sunday newspapers.
As awareness of vascular anomalies grows and research on effective treatments continues, this natural offshoot of hematology and oncology offers a fertile area for career development.
email article
Most patients with hormone receptor (HR)-positive metastatic breast cancer should receive up to three lines of endocrine therapy as part of guideline-recommended care before starting chemotherapy, said Hope S. Rugo, MD, director of Breast Oncology and Clinical Trials Education at the Helen Diller Family Comprehensive Cancer Center of the University of California San Francisco. Almost every patient will acquire resistance to endocrine therapy over time, Rugo told
MedPage Today. Some patients will develop resistance in the first year of treatment sometimes within months and some can stay on their first-line endocrine therapy for 7 to 10 years. We don t have a clear understanding of the specific factors that control time to development of acquired resistance, although there are clearly clinical and biologic indications of risk.